Brief: Cara Therapeutics Reports Third Quarter 2022 Financial Results

Tvardi Therapeutics

07/11/2022 22:54

Nov 7 (Reuters) - Cara Therapeutics Inc  CARA.O :
    * Q3 REVENUE $16.2 MILLION
    * CARA THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
    * Q3 LOSS PER SHARE $0.43
    * Q3 EARNINGS PER SHARE VIEW $-0.42, REVENUE VIEW $9.8
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX8nqJs 
Further company coverage:  CARA.O 
 ((Reuters.Briefs@thomsonreuters.com;))